ekso bionics holdings inc - EKSO

EKSO

Close Chg Chg %
10.65 -1.25 -11.74%

Closed Market

9.40

-1.25 (11.74%)

Volume: 217.84K

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: ekso bionics holdings inc - EKSO

EKSO Key Data

Open

$10.21

Day Range

9.20 - 10.44

52 Week Range

2.75 - 13.50

Market Cap

$33.50M

Shares Outstanding

3.56M

Public Float

2.67M

Beta

0.78

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$5.06

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

82.20K

 

EKSO Performance

1 Week
 
-7.39%
 
1 Month
 
-17.40%
 
3 Months
 
19.90%
 
1 Year
 
65.78%
 
5 Years
 
-90.13%
 

EKSO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About ekso bionics holdings inc - EKSO

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

EKSO At a Glance

Ekso Bionics Holdings, Inc.
101 Glacier Point
San Rafael, California 94901
Phone 1-510-984-1761 Revenue 12.80M
Industry Medical Specialties Net Income -11,921,000.00
Sector Health Technology Employees 55
Fiscal Year-end 12 / 2026
View SEC Filings

EKSO Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.638
Price to Book Ratio 3.406
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -2.079
Enterprise Value to Sales 1.909
Total Debt to Enterprise Value 0.19

EKSO Efficiency

Revenue/Employee 232,709.091
Income Per Employee -216,745.455
Receivables Turnover 1.751
Total Asset Turnover 0.547

EKSO Liquidity

Current Ratio 1.627
Quick Ratio 1.068
Cash Ratio 0.135

EKSO Profitability

Gross Margin 57.137
Operating Margin -104.118
Pretax Margin -91.374
Net Margin -93.14
Return on Assets -50.985
Return on Equity -109.699
Return on Total Capital -87.199
Return on Invested Capital -88.353

EKSO Capital Structure

Total Debt to Total Equity 51.446
Total Debt to Total Capital 33.97
Total Debt to Total Assets 23.092
Long-Term Debt to Equity 10.469
Long-Term Debt to Total Capital 6.912
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Ekso Bionics Holdings Inc - EKSO

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
12.91M 18.28M 17.93M 12.80M
Sales Growth
+14.81% +41.57% -1.94% -28.60%
Cost of Goods Sold (COGS) incl D&A
6.27M 8.58M 7.68M 5.49M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
887.00K 1.70M 1.61M 1.57M
Depreciation
864.00K 1.37M 1.30M 1.24M
Amortization of Intangibles
23.00K 325.00K 312.00K 330.00K
COGS Growth
+49.61% +36.79% -10.45% -28.60%
Gross Income
6.64M 9.70M 10.24M 7.31M
Gross Income Growth
-5.87% +46.08% +5.60% -28.59%
Gross Profit Margin
+51.42% +53.06% +57.13% +57.14%
2022 2023 2024 2025 5-year trend
SG&A Expense
21.77M 24.19M 19.97M 20.17M
Research & Development
3.63M 5.03M 3.87M 3.03M
Other SG&A
18.14M 19.17M 16.10M 17.14M
SGA Growth
+5.80% +11.12% -17.44% +1.00%
Other Operating Expense
425.00K 619.00K 730.00K 468.00K
Unusual Expense
(1.32M) 133.00K (365.00K) (1.00K)
EBIT after Unusual Expense
(14.24M) (15.25M) (10.10M) (13.33M)
Non Operating Income/Expense
(685.00K) 349.00K (966.00K) 1.94M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
156.00K 302.00K 269.00K 309.00K
Interest Expense Growth
+38.05% +93.59% -10.93% +14.87%
Gross Interest Expense
156.00K 302.00K 269.00K 309.00K
Interest Capitalized
- - - -
-
Pretax Income
(15.08M) (15.20M) (11.33M) (11.70M)
Pretax Income Growth
-54.44% -0.78% +25.45% -3.22%
Pretax Margin
-116.79% -83.14% -63.21% -91.37%
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (226.00K)
-
Consolidated Net Income
(15.08M) (15.20M) (11.33M) (11.92M)
Minority Interest Expense
- - - -
-
Net Income
(15.08M) (15.20M) (11.33M) (11.92M)
Net Income Growth
-54.44% -0.78% +25.45% -5.22%
Net Margin Growth
-116.79% -83.14% -63.21% -93.14%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(15.08M) (15.20M) (11.33M) (11.92M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(15.08M) (15.20M) (11.33M) (11.92M)
EPS (Basic)
-17.451 -16.4397 -8.4297 -4.9138
EPS (Basic) Growth
-45.28% +5.80% +48.72% +41.71%
Basic Shares Outstanding
864.13K 924.47K 1.34M 2.43M
EPS (Diluted)
-17.451 -16.4397 -8.4297 -4.9138
EPS (Diluted) Growth
-32.25% +5.80% +48.72% +41.71%
Diluted Shares Outstanding
864.13K 924.47K 1.34M 2.43M
EBITDA
(14.67M) (13.41M) (8.85M) (11.75M)
EBITDA Growth
-10.57% +8.56% +34.01% -32.77%
EBITDA Margin
-113.61% -73.38% -49.38% -91.83%

Snapshot

Average Recommendation HOLD Average Target Price 90.00
Number of Ratings 1 Current Quarters Estimate -0.063
FY Report Date 06 / 2026 Current Year's Estimate -0.103
Last Quarter’s Earnings -0.032 Median PE on CY Estimate N/A
Year Ago Earnings -0.87 Next Fiscal Year Estimate -0.06
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate -0.06 -0.02 -0.10 -0.06
High Estimates -0.06 -0.02 -0.10 -0.06
Low Estimate -0.06 -0.02 -0.10 -0.06
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 1
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Overweight

Insider Actions for Ekso Bionics Holdings Inc - EKSO

Date Name Shares Transaction Value
Feb 20, 2026 Daniel Asher 259,992 Open market or private purchase of non-derivative security Non-derivative transaction at $9.6 per share 2,495,923.20

Ekso Bionics Holdings Inc in the News